title: [Cardiovascular diseases in pregnancy: facts of the new guideline].
authors.affiliation: Institut für Geschlechterforschung in der Medizin (GIM), Charité-Universitätsmedizin Berlin Campus Mitte, Luisenstrasse 65, Berlin. ute.seeland@charite.de
authors.forename: U
authors.initials: U
authors.lastname: Seeland
authors.forename: P
authors.initials: P
authors.lastname: Goldin-Lang
authors.forename: V
authors.initials: V
authors.lastname: Regitz-Zagrosek
mesh_terms: D000784:Aortic Dissection / Q000175:diagnosis / Q000628:therapy; D001014:Aortic Aneurysm / Q000175:diagnosis / Q000628:therapy; D009202:Cardiomyopathies / Q000175:diagnosis / Q000628:therapy; D002317:Cardiovascular Agents / Q000009:adverse effects / Q000627:therapeutic use; D003299:Cooperative Behavior; D005260:Female; D006330:Heart Defects, Congenital / Q000175:diagnosis / Q000628:therapy; D006349:Heart Valve Diseases / Q000175:diagnosis / Q000628:therapy; D006350:Heart Valve Prosthesis; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000628:therapy; D007231:Infant, Newborn; D033183:Interdisciplinary Communication; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000175:diagnosis / Q000628:therapy*; D011296:Prenatal Diagnosis; D018570:Risk Assessment; D054556:Venous Thromboembolism / Q000175:diagnosis / Q000628:therapy
chemical_list: D002317:Cardiovascular Agents